IL129473A0 - Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof - Google Patents

Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof

Info

Publication number
IL129473A0
IL129473A0 IL12947397A IL12947397A IL129473A0 IL 129473 A0 IL129473 A0 IL 129473A0 IL 12947397 A IL12947397 A IL 12947397A IL 12947397 A IL12947397 A IL 12947397A IL 129473 A0 IL129473 A0 IL 129473A0
Authority
IL
Israel
Prior art keywords
etherlipid
therapeutic uses
carriers containing
lipid combination
shape lipid
Prior art date
Application number
IL12947397A
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of IL129473A0 publication Critical patent/IL129473A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12947397A 1996-10-15 1997-10-15 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof IL129473A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/720,997 US5932242A (en) 1996-10-15 1996-10-15 Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof
PCT/US1997/018546 WO1998016200A1 (en) 1996-10-15 1997-10-15 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
IL129473A0 true IL129473A0 (en) 2000-02-29

Family

ID=24896093

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12947397A IL129473A0 (en) 1996-10-15 1997-10-15 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof

Country Status (18)

Country Link
US (2) US5932242A (no)
EP (1) EP0966266A4 (no)
JP (1) JP2001502332A (no)
KR (1) KR100512689B1 (no)
CN (1) CN1088582C (no)
AU (1) AU722092B2 (no)
BR (1) BR9712329A (no)
CA (1) CA2268841A1 (no)
CZ (1) CZ131799A3 (no)
HK (1) HK1024638A1 (no)
HU (1) HUP0000523A3 (no)
IL (1) IL129473A0 (no)
NO (1) NO991770L (no)
NZ (1) NZ335125A (no)
PL (1) PL190711B1 (no)
SK (1) SK283817B6 (no)
TR (1) TR199900799T2 (no)
WO (1) WO1998016200A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
US20060116354A1 (en) * 2003-01-09 2006-06-01 Perkins Walter R Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
US20060135765A1 (en) * 2003-01-09 2006-06-22 Perkins Walter R Antineoplastic ether lipid compounds
US20060048659A1 (en) * 2003-01-16 2006-03-09 Hunter Douglas Inc. Covering for architectural surfaces and method of forming and applying same
DK1740591T3 (da) 2004-04-02 2009-10-26 Osi Pharm Inc Heterobicykliske proteinkinaseinhibitorer substitueret med en 6,6-biocyclisk ring
PT1827379E (pt) * 2004-10-19 2011-03-23 Max Planck Gesellschaft Formulações contendo alquilfosfocolinas usando novos portadores de carga negativa
JP5382974B2 (ja) * 2005-03-11 2014-01-08 太陽化学株式会社 化粧料用組成物及び化粧料
KR100829595B1 (ko) 2006-12-11 2008-05-14 한국화학연구원 당이 결합된 인지질로 수식된 리포솜 및 이의 제조방법
WO2011101408A1 (en) 2010-02-18 2011-08-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for preventing cancer metastasis
US11447485B2 (en) 2016-12-14 2022-09-20 Beijing Showby Pharmaceutical Co., Ltd. Class of bifunctional compounds with quanternary ammonium salt structure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
ATE198419T1 (de) * 1994-10-14 2001-01-15 Liposome Co Inc Etherlipid-liposomen und deren therapeutische verwendung

Also Published As

Publication number Publication date
HUP0000523A2 (hu) 2000-09-28
HUP0000523A3 (en) 2000-10-30
JP2001502332A (ja) 2001-02-20
SK49399A3 (en) 1999-11-08
TR199900799T2 (xx) 1999-07-21
EP0966266A1 (en) 1999-12-29
CZ131799A3 (cs) 1999-08-11
KR20000049128A (ko) 2000-07-25
AU4756797A (en) 1998-05-11
NO991770D0 (no) 1999-04-14
US5932242A (en) 1999-08-03
AU722092B2 (en) 2000-07-20
BR9712329A (pt) 1999-08-31
US6017557A (en) 2000-01-25
WO1998016200A1 (en) 1998-04-23
SK283817B6 (sk) 2004-02-03
CN1088582C (zh) 2002-08-07
PL190711B1 (pl) 2005-12-30
PL332696A1 (en) 1999-09-27
NZ335125A (en) 1999-11-29
NO991770L (no) 1999-06-09
KR100512689B1 (ko) 2005-09-07
CN1240348A (zh) 2000-01-05
HK1024638A1 (en) 2000-10-20
CA2268841A1 (en) 1998-04-23
EP0966266A4 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
EP1015578A4 (en) THERAPEUTIC MOLECULES
GB9610129D0 (en) Patient support
GB9601724D0 (en) Therapeutic agents
GB9600235D0 (en) Therapeutic agents
HUP0000523A3 (en) Carriers containing an entherlipid/complementarily shape lipid combination and therapeutic uses thereof
GB9816038D0 (en) Medical support
GB2330526B (en) Patient support
GB9726701D0 (en) Therapeutic use
GB9603136D0 (en) Therapeutic agents
GB2290232B (en) Body and back support
ZA977005B (en) Therapeutic uses
GB0120368D0 (en) Assays therapeutic methods and means
GB9601786D0 (en) Therapeutic agents
CA80339S (en) Infant's mobile
GB9720258D0 (en) Extravise and Inavise
GB9614121D0 (en) Combined medicament
GB9904141D0 (en) Therapeutic gene
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
TW357555U (en) Patient trousures
GB9605466D0 (en) Therapy
TW387250U (en) Patient carrier
GB9704290D0 (en) Medical support
GB9502524D0 (en) Patient inbed support
GB9708288D0 (en) Therapeutic use
GB9726700D0 (en) Therapeutic use